US case analysis: Myriad at the Supreme Court

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

US case analysis: Myriad at the Supreme Court

Managing IP Correspondent
August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

FeaturesMIP Special FocusLife Sciences 2013 (August 2013)
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Copyright
Barristers.png
Two IP barristers among latest group to ‘take silk’
IP specialists Jonathan Moss and Jessie Bowhill, who worked on cases concerning bitcoin, Ed Sheeran, and the Getty v Stability AI dispute, received the KC nod
January 29 2026
Patents
Beautiful skyline of Dubai city at night in United Arab Emirates
Weekly take: AIPPI’s Dubai decision shows DEI is a ‘tick box’ exercise
Hannah Brown, an active AIPPI member, argues that DEI commitments must be backed up with actions, not just words
Hannah Brown, January 29 2026
Patents
A lot of Kodak film cartridge. :Latvia, Talsi, february 5, 2024
UPC update: Kodak hit with €1.7m penalty | CoA judges take oath
A ruling in the Kodak v Fujifilm dispute and a win for Google were among the major recent developments
Max Walters, January 29 2026
Trademarks
A 3D cartoon soccer player in a white uniform with "Beckham 23" kicks the ball on a vibrant green field.
Brand it like Beckham: the rights to celebrity names
Nick Aries and Elizabeth Louca at Bird & Bird unpick the legal questions raised by a very public social media spat concerning the ‘Brooklyn Beckham’ trademark
Nick Aries, January 28 2026
Trademarks
Michael C.jpg
To the next level: Birketts’ new TM lead eyes ‘end-to-end’ service
Michael Conway, who joined Birketts after nearly two decades at an IP boutique, says he was intrigued by the challenge of joining a general practice firm
Max Walters, January 28 2026
Patents
Murgi.png
Murgitroyd adds to senior leadership team with Eversheds and DLA hires
The private-equity-backed firm said hires from DLA Piper and Eversheds Sutherland will help it become the IP partner of choice for innovative businesses
January 27 2026
Trademarks
Purell.jpg
Cooley, Jones Day act on Clorox’s $2.25bn acquisition of Purell-maker
The acquisition is expected to help Clorox bolster its position in the health and hygiene consumer products market
Sukanya Sarkar, January 27 2026
Patents
Dubai city by night
AIPPI sticks with Dubai for World Congress despite industry pressure
AIPPI, which has faced boycott threats over the 2027 World Congress, says it has a long-standing commitment to engagement and geographic rotation
January 27 2026
Managing IP Awards
Awards.jpg
Managing IP Americas Awards 2026: shortlists to be revealed
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
Sanjana Mishra, January 26 2026
Patents
Playboy.jpg
This week on MIP: Maxim sues Playboy | Brand Beckham under fire
News of Nokia signing a licensing deal with a Chinese automaker and Linklaters appointing a new head of tech and IP were also among the top talking points
Max Walters, January 23 2026
Gift this article